CWLXFOTCMedicinal Chemicals & Botanical ProductsFiscal year ends March 31

C21 Investments Inc.

Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Jun 12, 2026

Share price

Not available yet

Price, market cap and P/E appear here once daily prices are connected.

C21 Investments Inc. income statement

AnnualQuarterlyTTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2026 2026-03-31	FY 2024 2024-01-31	FY 2023 2023-01-31	FY 2022 2022-01-31	FY 2021 2021-01-31	FY 2020 2020-01-31	FY 2019 2019-01-31	FY 2018 2018-01-31
Revenue	33	28	29	33	33	38	2.59	–
Cost of Revenue	19	17	15	14	15	26	2.68	–
Gross Profit	14	11	13	19	18	13	0.18	–
Selling, General & Admin	11	9.68	9.45	9.06	8.81	1.62	2.49	–
Selling & Marketing	0.24	0.08	0.08	0.08	0.17	1.12	2.31	–
General & Administrative	8.23	–	–	–	0.42	0.50	0.19	0.03
Operating Expenses	–	–	–	–	–	14	12	–
Operating Income	2.28	1.47	3.96	9.75	9.24	-1.18	-12	-0.60
Interest Expense	0.19	0.04	0.46	1.08	3.93	3.87	0.39	–
Interest & Investment Income	0.03	–	–	–	–	–	–	–
Asset Impairment Charges	–	1.20	0.02	–	–	–	–	–
Gain (Loss) on Sale of Assets	0.01	-0.01	0	0	0.14	–	–	–
Pretax Income	1.38	0.26	4.19	17	-1.63	-29	-24	-0.60
Income Tax Expense	4.61	3.48	2.81	4.93	2.97	3.71	0	0
Income from Continuing Operations	-3.24	-3.22	1.38	12	-4.60	–	–	–
Income from Discontinued Operations	-0.01	-0.08	-1.09	-2.24	-3.23	–	–	–
Net Income incl. Noncontrolling Interests	–	–	–	–	-6.11	-33	-24	-0.60
Net Income	-3.24	-3.31	0.29	9.95	-7.83	–	–	–
EPS (Basic)(per share)	-0.03	-0.03	0.00	0.08	-0.07	-0.42	-0.76	-0.11
EPS (Diluted)(per share)	-0.03	-0.03	0.00	0.08	-0.07	-0.43	-0.76	-0.11
Shares Outstanding (Basic, Weighted)(shares)	118	120	120	118	105	77	31	5.00
Shares Outstanding (Diluted, Weighted)(shares)	118	123	123	121	105	77	31	5.00
EBITDA	4.06	2.88	5.80	12	12	3.80	-11	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Mar 31, 2026

Profitability, FY2026

Gross margin: 41.7%
Operating margin: 7.0%
Net margin: -9.9%
Return on equity, FY2026: -11.5%

Financial strength

Current ratio: 1.30
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 35.0%

Valuation

P/E ratio: –
Price to sales: –
Price to book: –
Dividend yield: –

Valuation ratios need the share price and fill in once daily prices are connected.